These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2619 related items for PubMed ID: 15776115

  • 21. National patterns of warfarin use in atrial fibrillation.
    Stafford RS, Singer DE.
    Arch Intern Med; ; 156(22):2537-41. PubMed ID: 8951296
    [Abstract] [Full Text] [Related]

  • 22. [Nonvalvular atrial fibrillation: thromboembolic risk assessment and therapy in a general practice population].
    Del Zotti F, Gottardi G, Frapporti G, Micchi A, Zanolla L.
    G Ital Cardiol (Rome); 2010 Apr; 11(4):313-7. PubMed ID: 20677578
    [Abstract] [Full Text] [Related]

  • 23. Physician specialty is associated with differences in warfarin use for atrial fibrillation.
    Kellen JC, Russell ML.
    Can J Cardiol; 1998 Mar; 14(3):365-8. PubMed ID: 9551030
    [Abstract] [Full Text] [Related]

  • 24. Antithrombotic therapy in atrial fibrillation: an assessment of compliance with guidelines.
    Nair A, Hazell W, Sutton T, Pillai S.
    N Z Med J; 2005 Jan 28; 118(1208):U1258. PubMed ID: 15682210
    [Abstract] [Full Text] [Related]

  • 25. Stroke prevention in atrial fibrillation: are we following the guidelines?
    Pusser BE, Robertson SL, Robinson MD, Barton C, Dobson LA.
    N C Med J; 2005 Jan 28; 66(1):9-13. PubMed ID: 15786672
    [Abstract] [Full Text] [Related]

  • 26. [Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial].
    Bücheler R, Meisner C, Mörike K, Fux R, Hauswald K, Lorenz G, Kühlkamp V, Gleiter CH, AFib Trial.
    Z Arztl Fortbild Qualitatssich; 2003 Jan 28; 97(6):421-31. PubMed ID: 14524058
    [Abstract] [Full Text] [Related]

  • 27. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P, Bricard M, Hermann MA, Cotté FE, Deret-Bixio L, Rushton-Smith S.
    Arch Cardiovasc Dis; 2015 Nov 28; 108(11):544-53. PubMed ID: 26113478
    [Abstract] [Full Text] [Related]

  • 28. Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives.
    Levi M, Hobbs FD, Jacobson AK, Pisters R, Prisco D, Bernardo A, Haas M, Heidrich J, Rosenberg M, Nielsen JD, Wuillemin WA.
    Semin Thromb Hemost; 2009 Sep 28; 35(6):527-42. PubMed ID: 19787556
    [Abstract] [Full Text] [Related]

  • 29. [Guidelines and clinical practice: anticoagulant therapy and cardioversion in atrial fibrillation].
    Callegari S, Pini M, Andreoli L.
    G Ital Cardiol; 1999 Oct 28; 29(10):1157-63. PubMed ID: 10546125
    [Abstract] [Full Text] [Related]

  • 30. Comorbidity associated with atrial fibrillation: a general practice-based study.
    Carroll K, Majeed A.
    Br J Gen Pract; 2001 Nov 28; 51(472):884-6, 889-91. PubMed ID: 11761201
    [Abstract] [Full Text] [Related]

  • 31. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ, Petrie A, Goldsmith CH, Marentette MA.
    Am J Manag Care; 2004 Nov 28; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [Abstract] [Full Text] [Related]

  • 32. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK, Vécsei L.
    Ideggyogy Sz; 2008 May 30; 61(5-6):148-54. PubMed ID: 18567389
    [Abstract] [Full Text] [Related]

  • 33. Community-based study of atrial fibrillation and stroke prevention.
    White S, Feely J, O'Neill D.
    Ir Med J; 2004 Jan 30; 97(1):10-2. PubMed ID: 15055913
    [Abstract] [Full Text] [Related]

  • 34. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 30; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 35. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, Bauersachs R.
    Thromb Haemost; 2012 Jun 30; 107(6):1053-65. PubMed ID: 22398417
    [Abstract] [Full Text] [Related]

  • 36. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B.
    Thromb Haemost; 2010 Apr 30; 103(4):833-40. PubMed ID: 20135077
    [Abstract] [Full Text] [Related]

  • 37. Anticoagulation for patients with atrial fibrillation in ambulatory care settings.
    Niska R, Han B.
    J Am Board Fam Med; 2009 Apr 30; 22(3):299-306. PubMed ID: 19429736
    [Abstract] [Full Text] [Related]

  • 38. Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe.
    Bhagat K, Tisocki K.
    Cent Afr J Med; 1999 Nov 30; 45(11):287-90. PubMed ID: 10892453
    [Abstract] [Full Text] [Related]

  • 39. Orthopaedists' and family practitioners' knowledge of simple low back pain management.
    Finestone AS, Raveh A, Mirovsky Y, Lahad A, Milgrom C.
    Spine (Phila Pa 1976); 2009 Jul 01; 34(15):1600-3. PubMed ID: 19564770
    [Abstract] [Full Text] [Related]

  • 40. Underutilization of oral anticoagulant therapy for stroke prevention in elderly patients with heart failure.
    Ibrahim SA, Kwoh CK.
    Am Heart J; 2000 Aug 01; 140(2):219-20. PubMed ID: 10925333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 131.